TX SB670

Allows patients to access investigational sun protection products that have completed phase one clinical trials but not yet received FDA approval, if their physician determines FDA-approved products are less effective and provides a written recommendation or prescription

Requires patients to sign a written informed consent form before receiving investigational products; parents or legal guardians may consent for minors or patients lacking mental capacity

Permits manufacturers to provide investigational sun protection products to eligible patients either free of charge or at manufacturing cost, but does not require manufacturers to make products available

Prohibits private or state causes of action against manufacturers, physicians, or other entities for harm resulting from use of investigational sun protection products under this chapter

Protects physicians from Texas Medical Board disciplinary action based solely on recommending or prescribing investigational sun protection products to eligible patients, provided they meet medical standard of care requirements